Integrative epidemiology: from risk assessment to outcome prediction.
about
Integrative cancer epidemiology--the next generationGenetic variants of miRNA sequences and non-small cell lung cancer survivalPersonalized exposure assessment: promising approaches for human environmental health research.The evolving discipline of molecular epidemiology of cancer.Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patientsGenetic variation in microRNA networks: the implications for cancer research.Genetically InFormed therapies--a "GIFT" for children with cancerGenetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma.Racial and ethnic disparities in risk and survival in children with neuroblastoma: a Children's Oncology Group study.The use of genomic information to optimize cancer chemotherapyGenomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer.Epidemiological study of prostate cancer (EPICAP): a population-based case-control study in FrancePrognostic relevance of urinary bladder cancer susceptibility loci.ERCC1 and ERCC2 polymorphisms and adult glioma.Advances in breast cancer: pathways to personalized medicineMolecular epidemiology, cancer-related symptoms, and cytokines pathway.Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles?Identifying genetic variants that contribute to chemotherapy-induced cytotoxicityDissecting the heterogeneity of schizophrenia outcomesEffect of population and gender on chemotherapeutic agent-induced cytotoxicity.Polymorphisms in tissue inhibitors of metalloproteinases-2 and -3 and breast cancer susceptibility and survival.Genetic polymorphisms in the precursor MicroRNA flanking region and non-small cell lung cancer survival.Polymorphism and overexpression of HER2/neu among ovarian carcinoma women from Tiruchirapalli, Tamil Nadu, India.
P2860
Q24594622-A8875E61-7793-49C7-88AD-A07EDC4CDB20Q24648054-D1751624-149F-4F9F-B537-B387F4D16C54Q24813494-1DC65D4E-66BA-496E-BA3B-D86B9A3480D0Q33575696-CFA3093D-50A9-4130-AB80-E9C9BECB1E40Q33645629-DCEA1585-EAAE-4D0B-9A59-CC3709636FF3Q34177121-950C3A8F-D9C6-4AD7-BDCE-46977993CFBDQ34270304-B0312BDF-886D-438E-94AE-DF73C59BD75FQ34310416-D0A6FAFE-890C-44F7-B97E-7498CDDDFD7AQ34662881-3C49B433-EA87-4F32-8E6F-2A8393C65FFEQ34791981-91CDE57A-8DDF-4EBF-A0A8-093DD485CB34Q35058278-4B586E70-36F1-491E-A2FF-CB967001F88EQ35098158-0111818E-30A6-443F-B9D0-FE42B2B9B56CQ35106772-6881BA9E-3E22-435D-B1FF-25ADA2254350Q35800114-2BC9BC03-6A60-4E11-8ADE-2D34590041F1Q35951346-DCAAC9AB-2C1D-49EB-A9D0-18B1F0572694Q36079191-EAD11BFE-7BFC-4E33-9B7D-3670F13E3D37Q36332992-3E754111-C59B-4473-BDFD-B7FD7288A6A5Q36966019-CABF264E-F59F-4905-B558-A4CF1AC1A466Q37076273-95658C9E-2C56-4FDC-BF53-4FEFDCE99CC4Q37159518-DF99F659-A7D9-4A0A-B350-63151C955DC2Q37351433-57CF097B-D18C-4ED5-820F-E92622FA806FQ44069881-1BE9BBCB-F4C1-4224-B5C3-359DB627D7C4Q50949600-3D12276A-3DFC-4EF1-949A-11F1CEAD8EC1
P2860
Integrative epidemiology: from risk assessment to outcome prediction.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Integrative epidemiology: from risk assessment to outcome prediction.
@ast
Integrative epidemiology: from risk assessment to outcome prediction.
@en
type
label
Integrative epidemiology: from risk assessment to outcome prediction.
@ast
Integrative epidemiology: from risk assessment to outcome prediction.
@en
prefLabel
Integrative epidemiology: from risk assessment to outcome prediction.
@ast
Integrative epidemiology: from risk assessment to outcome prediction.
@en
P2093
P356
P1476
Integrative epidemiology: from risk assessment to outcome prediction.
@en
P2093
Gordon Mills
Margaret R Spitz
P304
P356
10.1200/JCO.2005.05.122
P407
P577
2005-01-01T00:00:00Z